The Mucosa-associated Microbiota of PSC Patients is Characterized by Low Diversity and Low Abundance of Uncultured Clostridiales II
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Mucosa-associated Microbiota of PSC Patients is Characterized by Low Diversity and Low Abundance of Uncultured Clostridiales II
Authors
Keywords
-
Journal
Journal of Crohns & Colitis
Volume 9, Issue 4, Pages 342-348
Publisher
Oxford University Press (OUP)
Online
2014-12-30
DOI
10.1093/ecco-jcc/jju023
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tipping elements in the human intestinal ecosystem
- (2014) Leo Lahti et al. Nature Communications
- Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis
- (2013) Kirsten Boonstra et al. HEPATOLOGY
- Phylogenetic Analysis of Dysbiosis in Ulcerative Colitis During Remission
- (2013) Mirjana Rajilić-Stojanović et al. INFLAMMATORY BOWEL DISEASES
- Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity
- (2013) Anne Vrieze et al. JOURNAL OF HEPATOLOGY
- Altered profile of human gut microbiome is associated with cirrhosis and its complications
- (2013) Jasmohan S. Bajaj et al. JOURNAL OF HEPATOLOGY
- Richness of human gut microbiome correlates with metabolic markers
- (2013) Emmanuelle Le Chatelier et al. NATURE
- Diet rapidly and reproducibly alters the human gut microbiome
- (2013) Lawrence A. David et al. NATURE
- Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
- (2013) Els van Nood et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gut Microbiomes of Malawian Twin Pairs Discordant for Kwashiorkor
- (2013) M. I. Smith et al. SCIENCE
- Long-term monitoring of the human intestinal microbiota composition
- (2012) Mirjana Rajilić-Stojanović et al. ENVIRONMENTAL MICROBIOLOGY
- Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
- (2012) Henri Duboc et al. GUT
- Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease
- (2012) Kirsten Boonstra et al. INFLAMMATORY BOWEL DISEASES
- Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review
- (2012) Kirsten Boonstra et al. JOURNAL OF HEPATOLOGY
- Primary Sclerosing Cholangitis and Disease Distribution in Inflammatory Bowel Disease
- (2011) Aoibhlinn O'Toole et al. Clinical Gastroenterology and Hepatology
- Guidelines for the management of inflammatory bowel disease in adults
- (2011) C. Mowat et al. GUT
- Malignancies and mortality in 200 patients with primary sclerosering cholangitis: a long-term single-centre study
- (2011) Johan Fevery et al. LIVER INTERNATIONAL
- Mucolytic Bacteria With Increased Prevalence in IBD Mucosa Augment In Vitro Utilization of Mucin by Other Bacteria
- (2010) Chin Wen Png et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Inflammatory Bowel Disease
- (2010) Arthur Kaser et al. Annual Review of Immunology
- A Pyrosequencing Study in Twins Shows That Gastrointestinal Microbial Profiles Vary With Inflammatory Bowel Disease Phenotypes
- (2010) Ben P. Willing et al. GASTROENTEROLOGY
- Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression
- (2010) Emmanouil Sinakos et al. HEPATOLOGY
- Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults
- (2009) Mirjana Rajilić-Stojanović et al. ENVIRONMENTAL MICROBIOLOGY
- Low counts of Faecalibacterium prausnitzii in colitis microbiota
- (2009) H. Sokol et al. INFLAMMATORY BOWEL DISEASES
- EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
- (2009) JOURNAL OF HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started